earnings
confidence high
sentiment positive
materiality 0.80
Merit Medical Q2 revenue $338M (+5.6%), GAAP EPS $0.61 (+75.7%), raises FY guidance
MERIT MEDICAL SYSTEMS INC
2024-Q2 EPS reported
$1.09
revenue$661,511,000
- Revenue $338.0M, up 5.6% YoY; constant currency revenue up 6.6%.
- GAAP EPS $0.61, up 75.7%; Non-GAAP EPS $0.92, up 16.8%.
- GAAP operating margin 13.6% vs 9.0%; Non-GAAP operating margin 20.1% vs 19.1%.
- Raised full-year 2024 revenue and EPS guidance.
- WRAPSODY WAVE study 6-month outcomes to be presented at CIRSE Sept 14-16; FDA PMA under review.